October 19, 2007
Cytyc approves Hologic merger
By Cory Hopkins
In the next step of their ongoing merger process, stockholders of Marlborough-based Cytyc Corp. today approved the company's merger with Hologic Inc. of Bedford, following yesterday's approval by Hologic stockholders.
More than 76 percent of the outstanding shares of Cytyc were voted in favor of the transaction, the company said.
At the close of the transaction between the two women's health companies, expected sometime next week, Cytyc stockholders will get about one half a share of Hologic common stock and $16.50 cash for each Cytyc share they own, for a total consideration of $6.2 billion.
More than 76 percent of the outstanding shares of Cytyc were voted in favor of the transaction, the company said.
At the close of the transaction between the two women's health companies, expected sometime next week, Cytyc stockholders will get about one half a share of Hologic common stock and $16.50 cash for each Cytyc share they own, for a total consideration of $6.2 billion.
WBJ Web Partners
Most Recent
Most Recent
0 Comments